Effect of raloxifene on IGF-I and IGFBP-3 in postmenopausal women with breast cancer

The effect on the IGF system of 60 mg and 600 mg daily of raloxifene administered for 2 weeks prior to surgery was investigated in 37 postmenopausal women with breast cancer. Raloxifene significantly decreased insulin-like growth factor (IGF-I) as compared to placebo (P < 0.05) with no dose–respo...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Torrisi, R, Baglietto, L, Johansson, H, Veronesi, G, Bonanni, B, Guerrieri-Gonzaga, A, Ballardini, B, Decensi, A
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2001
Témata:
Regular Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2364027/
https://ncbi.nlm.nih.gov/pubmed/11747323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2001.2191
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky